Arbutus Biopharma (ABUS) Q1 2021 Earnings Call Transcript

·22 min read
Arbutus Biopharma (ABUS) Q1 2021 Earnings Call Transcript

Ladies and gentlemen, thank you for standing by, and welcome to the Arbutus Biopharma Corporation 2021 first-quarter financial results and corporate update conference call. On the call from Arbutus executive team are Bill Collier, president and chief executive officer; Dave Hastings, chief financial officer; Dr. Gaston Picchio, chief development officer; and Dr. Mike Sofia, chief scientific officer.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting